Reflections on the discovery of DNA vaccines

Methods

Volumn 31, Issue 3, 2003, Pages 181-182

  Felgner, Philip L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; DNA VACCINE; GENE PRODUCT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPID; NAKED DNA; RECOMBINANT PROTEIN;

ANTIGEN PRESENTATION; EDITORIAL; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; IN VIVO STUDY; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE;

HUMAN IMMUNODEFICIENCY VIRUS; VECTORS;

EID: 0141514412     PISSN: 10462023     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-2023(03)00131-2     Document Type: Editorial

References (7)

1. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
2. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Science. 247:1990;1465-1468.
3. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., Martin M., Felgner P.L. J. Biol. Chem. 269:1994;2550-2561.
4. Felgner P.L., Rhodes G. Nature. 349:1991;351-352.
5. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A.et al. Science. 259:1993;1745-1749.
6. Cohen J. Science. 259:1993;1691-1692.
7. Felgner P.L. Sci. Am. 276:1997;102-106.